EyePoint Pharmaceuticals Inc (EYPT)
8.345
-0.61
(-6.81%)
USD |
NASDAQ |
Nov 21, 16:00
8.345
0.00 (0.00%)
After-Hours: 20:00
EyePoint Pharmaceuticals Market Cap: 569.55M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 611.19M |
| November 19, 2024 | 628.59M |
| November 18, 2024 | 585.59M |
| November 15, 2024 | 625.86M |
| November 14, 2024 | 715.95M |
| November 13, 2024 | 734.38M |
| November 12, 2024 | 758.27M |
| November 11, 2024 | 819.01M |
| November 08, 2024 | 793.76M |
| November 07, 2024 | 791.03M |
| November 06, 2024 | 824.47M |
| November 05, 2024 | 792.39M |
| November 04, 2024 | 798.54M |
| November 01, 2024 | 823.11M |
| October 31, 2024 | 802.63M |
| October 30, 2024 | 613.39M |
| October 29, 2024 | 617.67M |
| October 28, 2024 | 648.72M |
| October 25, 2024 | 508.48M |
| October 24, 2024 | 511.69M |
| October 23, 2024 | 533.10M |
| October 22, 2024 | 575.39M |
| October 21, 2024 | 572.71M |
| October 18, 2024 | 591.44M |
| October 17, 2024 | 596.80M |
| Date | Value |
|---|---|
| October 16, 2024 | 603.76M |
| October 15, 2024 | 528.82M |
| October 14, 2024 | 544.34M |
| October 11, 2024 | 472.62M |
| October 10, 2024 | 441.04M |
| October 09, 2024 | 449.07M |
| October 08, 2024 | 453.89M |
| October 07, 2024 | 466.20M |
| October 04, 2024 | 461.92M |
| October 03, 2024 | 448.00M |
| October 02, 2024 | 439.44M |
| October 01, 2024 | 428.20M |
| September 30, 2024 | 427.66M |
| September 27, 2024 | 427.08M |
| September 26, 2024 | 431.89M |
| September 25, 2024 | 436.17M |
| September 24, 2024 | 446.34M |
| September 23, 2024 | 443.67M |
| September 20, 2024 | 476.85M |
| September 19, 2024 | 491.30M |
| September 18, 2024 | 476.85M |
| September 17, 2024 | 469.89M |
| September 16, 2024 | 473.10M |
| September 13, 2024 | 487.02M |
| September 12, 2024 | 475.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
51.06M
Minimum
Oct 28 2020
1.457B
Maximum
Feb 12 2024
341.92M
Average
279.44M
Median
Market Cap Benchmarks
| Cassava Sciences Inc | 1.549B |
| Regeneron Pharmaceuticals Inc | 81.80B |
| Adverum Biotechnologies Inc | 120.03M |
| Regenxbio Inc | 456.31M |
| Editas Medicine Inc | 196.05M |
Market Cap Related Metrics
| PS Ratio | 9.254 |
| Price to Book Value | 2.604 |
| Price | 8.345 |
| Earnings Yield | -23.85% |